ABT241101P117000
- 3.55
- +0.64+21.99%
Abbott Laboratories Newsroom
Argus Adjusts Price Target on Abbott Laboratories to $145 From $135
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $130 to $146
Abbott Labs Is Maintained at Neutral by Mizuho
Abbott Labs Price Target Raised to $130.00/Share From $115.00 by Mizuho
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $125 to $146
Abbott Laboratories Analyst Ratings
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential
Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
Evercore ISI Raises Abbott Laboratories Price Target to $128 From $124
Abbott Laboratories Analyst Ratings
Raymond James Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $129
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $127
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Buy Rating on Abbott Laboratories: Swift Clinical Advances and Strategic International Expansion
Citi Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $127